| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 3.06e-09 | 7 | 218 | 5 | GO:0004691 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.22e-09 | 37 | 218 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.55e-09 | 38 | 218 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 1.80e-08 | 9 | 218 | 5 | GO:0004690 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.74e-07 | 14 | 218 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 5.87e-07 | 16 | 218 | 5 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 1.52e-06 | 19 | 218 | 5 | GO:0032394 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.61e-06 | 21 | 218 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | MHC protein binding | 3.15e-06 | 58 | 218 | 7 | GO:0042287 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.29e-06 | 11 | 218 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | GPHN ERVK-6 TRPM7 MARK1 ERVK-7 ERVK-10 PTK2B PHKG2 NEK1 PIK3CG STK25 NPR2 CAMK2B POLR2A SCYL3 YES1 CDC42BPB PRKACA PRKACB ERVK-8 PRKACG ROCK1 PRKCQ POLQ PRKX PRKY | 1.26e-05 | 938 | 218 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRPM7 MARK1 PTK2B PHKG2 NEK1 PIK3CG STK25 CAMK2B CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 3.37e-05 | 446 | 218 | 16 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | TRPM7 MARK1 PTK2B PHKG2 NEK1 PIK3CG STK25 NPR2 CAMK2B SCYL3 YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 3.44e-05 | 600 | 218 | 19 | GO:0004672 |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 3.75e-05 | 18 | 218 | 4 | GO:0032393 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRPM7 MARK1 NEK1 PIK3CG STK25 CAMK2B CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 4.85e-05 | 363 | 218 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.54e-05 | 38 | 218 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | calcium ion binding | PADI4 CABYR FAT1 FAT2 CDH20 NAALADL1 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 ESYT3 PCDHGA12 SLIT1 ASPH FKBP7 PCDH1 | 7.69e-05 | 749 | 218 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | immune receptor activity | LILRB1 KIR2DL3 KIR2DS5 KIR3DL2 KIR3DS1 LILRA1 CR1L KIR3DL3 IL6ST | 8.59e-05 | 165 | 218 | 9 | GO:0140375 |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 1.19e-04 | 2 | 218 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | D-ribulose-phosphate 3-epimerase activity | 1.19e-04 | 2 | 218 | 2 | GO:0004750 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 1.46e-04 | 10 | 218 | 3 | GO:0004679 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 2.63e-04 | 12 | 218 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRPM7 MARK1 PTK2B PHKG2 NEK1 PIK3CG STK25 NPR2 CAMK2B SCYL3 YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 3.01e-04 | 709 | 218 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | nitrate reductase activity | 3.53e-04 | 3 | 218 | 2 | GO:0008940 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 3.91e-04 | 32 | 218 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 6.88e-04 | 37 | 218 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | phenylalanine-tRNA ligase activity | 7.02e-04 | 4 | 218 | 2 | GO:0004826 | |
| GeneOntologyMolecularFunction | kinase activity | TRPM7 MARK1 PTK2B PHKG2 NEK1 PIK3CG STK25 NPR2 CAMK2B SCYL3 YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 7.47e-04 | 764 | 218 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA hydrolase activity | 7.79e-04 | 17 | 218 | 3 | GO:0052816 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 7.79e-04 | 17 | 218 | 3 | GO:0000900 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 1.16e-03 | 5 | 218 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.28e-03 | 20 | 218 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.43e-03 | 152 | 218 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.57e-03 | 46 | 218 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 1.70e-03 | 22 | 218 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 1.73e-03 | 6 | 218 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | molybdopterin cofactor binding | 1.73e-03 | 6 | 218 | 2 | GO:0043546 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 2.40e-03 | 7 | 218 | 2 | GO:0023025 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate transfer activity | 2.40e-03 | 7 | 218 | 2 | GO:1902388 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 1.35e-08 | 187 | 219 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 4.67e-08 | 33 | 219 | 7 | GO:0065005 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 7.03e-07 | 48 | 219 | 7 | GO:0000731 | |
| GeneOntologyBiologicalProcess | protein-lipid complex organization | 2.95e-06 | 59 | 219 | 7 | GO:0071825 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 6.93e-06 | 313 | 219 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 8.20e-06 | 13 | 219 | 4 | GO:0034380 | |
| GeneOntologyBiologicalProcess | DNA integration | 8.20e-06 | 13 | 219 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle assembly | 1.24e-05 | 29 | 219 | 5 | GO:0034377 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | PSEN2 KIR2DS2 LILRB1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 SEC14L1 LILRA1 CACNB4 RAB11FIP2 YES1 EPG5 CD300LD KIR3DL3 PRKCQ INAVA | 3.31e-05 | 615 | 219 | 19 | GO:0002764 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DLG5 NCAM1 LILRB1 ITGB8 FAT1 NEO1 FAT2 CDH20 PIK3CG PDIA2 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 IGDCC3 YES1 PCDHGA12 ROCK1 PRKCQ PCDH1 IL6ST | 8.11e-05 | 1077 | 219 | 26 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translational elongation | 1.12e-04 | 2 | 219 | 2 | GO:1900248 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 1.34e-04 | 10 | 219 | 3 | GO:2000766 | |
| GeneOntologyBiologicalProcess | protein kinase A signaling | 1.52e-04 | 48 | 219 | 5 | GO:0010737 | |
| GeneOntologyBiologicalProcess | renal water homeostasis | 1.54e-04 | 26 | 219 | 4 | GO:0003091 | |
| Domain | Cadherin_tail | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 8.40e-12 | 37 | 214 | 10 | PF15974 |
| Domain | Cadherin_CBD | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 8.40e-12 | 37 | 214 | 10 | IPR031904 |
| Domain | Cadherin_CS | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 2.70e-11 | 109 | 214 | 14 | IPR020894 |
| Domain | Cadherin_C | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 3.38e-11 | 42 | 214 | 10 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 3.38e-11 | 42 | 214 | 10 | PF16492 |
| Domain | CADHERIN_1 | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 4.43e-11 | 113 | 214 | 14 | PS00232 |
| Domain | Cadherin | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 4.43e-11 | 113 | 214 | 14 | PF00028 |
| Domain | CADHERIN_2 | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 5.00e-11 | 114 | 214 | 14 | PS50268 |
| Domain | - | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 5.00e-11 | 114 | 214 | 14 | 2.60.40.60 |
| Domain | CA | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 5.64e-11 | 115 | 214 | 14 | SM00112 |
| Domain | Cadherin-like | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 6.35e-11 | 116 | 214 | 14 | IPR015919 |
| Domain | Cadherin | FAT1 FAT2 CDH20 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 8.02e-11 | 118 | 214 | 14 | IPR002126 |
| Domain | Cadherin_2 | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 1.80e-10 | 65 | 214 | 11 | PF08266 |
| Domain | Cadherin_N | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 1.80e-10 | 65 | 214 | 11 | IPR013164 |
| Domain | ig | KIR2DS2 NCAM1 LILRB1 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 LILRA1 IGDCC3 KIR3DL3 CEACAM20 | 4.18e-08 | 190 | 214 | 14 | PF00047 |
| Domain | Immunoglobulin | KIR2DS2 NCAM1 LILRB1 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 LILRA1 IGDCC3 KIR3DL3 CEACAM20 | 4.18e-08 | 190 | 214 | 14 | IPR013151 |
| Domain | IG | UNC5B KIR2DS2 NCAM1 LILRB1 IGSF10 NEO1 CD101 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 LILRA1 IGDCC3 CD300LD KIR3DL3 CEACAM20 | 4.14e-07 | 421 | 214 | 19 | SM00409 |
| Domain | Ig_sub | UNC5B KIR2DS2 NCAM1 LILRB1 IGSF10 NEO1 CD101 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 LILRA1 IGDCC3 CD300LD KIR3DL3 CEACAM20 | 4.14e-07 | 421 | 214 | 19 | IPR003599 |
| Domain | AGC-kinase_C | 3.39e-06 | 56 | 214 | 7 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.39e-06 | 56 | 214 | 7 | PS51285 | |
| Domain | S_TK_X | 3.39e-06 | 56 | 214 | 7 | SM00133 | |
| Domain | LAM_G_DOMAIN | 4.29e-06 | 38 | 214 | 6 | PS50025 | |
| Domain | CEBP_ZZ | 5.88e-06 | 4 | 214 | 3 | PF16366 | |
| Domain | RRM_7 | 5.88e-06 | 4 | 214 | 3 | PF16367 | |
| Domain | CEBP_ZZ | 5.88e-06 | 4 | 214 | 3 | IPR032296 | |
| Domain | Ig-like_fold | UNC5B KIR2DS2 NCAM1 LILRB1 IGSF10 NEO1 PTPRB CD101 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 USH2A LILRA1 IGDCC3 CD300LD KIR3DL3 EXOC2 CEACAM20 IL6ST | 6.76e-06 | 706 | 214 | 23 | IPR013783 |
| Domain | IG_LIKE | UNC5B KIR2DS2 NCAM1 LILRB1 IGSF10 NEO1 CD101 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 LILRA1 IGDCC3 CD300LD KIR3DL3 CEACAM20 | 1.52e-05 | 491 | 214 | 18 | PS50835 |
| Domain | Kinase-like_dom | TRPM7 MARK1 PTK2B PHKG2 NEK1 PIK3CG STK25 NPR2 CAMK2B SCYL3 YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 1.63e-05 | 542 | 214 | 19 | IPR011009 |
| Domain | Ig-like_dom | UNC5B KIR2DS2 NCAM1 LILRB1 IGSF10 NEO1 CD101 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 LILRA1 IGDCC3 CD300LD CEACAM20 | 2.09e-05 | 503 | 214 | 18 | IPR007110 |
| Domain | - | UNC5B KIR2DS2 NCAM1 LILRB1 IGSF10 NEO1 PTPRB CD101 SEMA3B KIR2DL2 KIR2DL3 KIR2DS3 KIR3DL2 KIR3DS1 USH2A LILRA1 IGDCC3 CD300LD EXOC2 CEACAM20 IL6ST | 2.63e-05 | 663 | 214 | 21 | 2.60.40.10 |
| Domain | Pkinase | MARK1 PHKG2 NEK1 STK25 NPR2 CAMK2B SCYL3 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 3.54e-05 | 381 | 214 | 15 | PF00069 |
| Domain | Prot_kinase_dom | MARK1 PTK2B PHKG2 NEK1 STK25 NPR2 CAMK2B SCYL3 YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 5.12e-05 | 489 | 214 | 17 | IPR000719 |
| Domain | Laminin_G | 5.20e-05 | 58 | 214 | 6 | IPR001791 | |
| Domain | PROTEIN_KINASE_DOM | MARK1 PTK2B PHKG2 NEK1 STK25 NPR2 CAMK2B SCYL3 YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 5.66e-05 | 493 | 214 | 17 | PS50011 |
| Domain | S_TKc | MARK1 PHKG2 NEK1 STK25 CAMK2B SCYL3 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 7.16e-05 | 359 | 214 | 14 | SM00220 |
| Domain | Laminin_G_2 | 8.95e-05 | 40 | 214 | 5 | PF02210 | |
| Domain | Protein_kinase_ATP_BS | MARK1 PTK2B PHKG2 NEK1 STK25 CAMK2B YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX | 1.27e-04 | 379 | 214 | 14 | IPR017441 |
| Domain | Alg10 | 1.31e-04 | 2 | 214 | 2 | IPR016900 | |
| Domain | Ribul_P_3_epim | 1.31e-04 | 2 | 214 | 2 | PF00834 | |
| Domain | DIE2_ALG10 | 1.31e-04 | 2 | 214 | 2 | PF04922 | |
| Domain | RIBUL_P_3_EPIMER_1 | 1.31e-04 | 2 | 214 | 2 | PS01085 | |
| Domain | Ribul_P_3_epim | 1.31e-04 | 2 | 214 | 2 | IPR026019 | |
| Domain | Ribul_P_3_epim-like | 1.31e-04 | 2 | 214 | 2 | IPR000056 | |
| Domain | Ser/Thr_kinase_AS | MARK1 PHKG2 NEK1 STK25 CAMK2B CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 2.54e-04 | 357 | 214 | 13 | IPR008271 |
| Domain | PROTEIN_KINASE_ATP | MARK1 PTK2B PHKG2 NEK1 STK25 CAMK2B YES1 CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 2.77e-04 | 459 | 214 | 15 | PS00107 |
| Domain | PROTEIN_KINASE_ST | MARK1 PHKG2 NEK1 STK25 CAMK2B CDC42BPB PRKACA PRKACB PRKACG ROCK1 PRKCQ PRKX PRKY | 2.90e-04 | 362 | 214 | 13 | PS00108 |
| Domain | RibuloseP-bd_barrel | 3.89e-04 | 3 | 214 | 2 | IPR011060 | |
| Domain | VDCC_L_bsu | 7.72e-04 | 4 | 214 | 2 | IPR000584 | |
| Domain | Bile_Hydr_Trans | 7.72e-04 | 4 | 214 | 2 | PF04775 | |
| Domain | VGCC_beta4Aa_N | 7.72e-04 | 4 | 214 | 2 | PF12052 | |
| Domain | Thio_Ohase/aa_AcTrfase | 7.72e-04 | 4 | 214 | 2 | IPR006862 | |
| Domain | Acyl-CoA_thioEstase_long-chain | 7.72e-04 | 4 | 214 | 2 | IPR016662 | |
| Domain | BAAT_C | 1.28e-03 | 5 | 214 | 2 | IPR014940 | |
| Domain | BAAT_C | 1.28e-03 | 5 | 214 | 2 | PF08840 | |
| Domain | Pkinase_C | 1.33e-03 | 42 | 214 | 4 | PF00433 | |
| Domain | LamG | 1.59e-03 | 44 | 214 | 4 | SM00282 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 1.03e-06 | 8 | 158 | 4 | M27840 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 1.70e-06 | 19 | 158 | 5 | M27841 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 3.14e-06 | 37 | 158 | 6 | M749 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 5.86e-06 | 41 | 158 | 6 | M512 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 7.01e-06 | 12 | 158 | 4 | M27363 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.36e-05 | 5 | 158 | 3 | M26988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 2.49e-05 | 16 | 158 | 4 | M47551 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.99e-05 | 54 | 158 | 6 | M26911 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 3.23e-05 | 17 | 158 | 4 | MM15561 | |
| Pathway | KEGG_PRION_DISEASES | 4.11e-05 | 35 | 158 | 5 | M13036 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 4.68e-05 | 7 | 158 | 3 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 4.68e-05 | 7 | 158 | 3 | MM15560 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 6.40e-05 | 20 | 158 | 4 | M759 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 6.67e-05 | 90 | 158 | 7 | M835 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ZSWIM8 PSEN2 UNC5B PSMC5 NCAM1 NEO1 SCN2A SCN7A CACNB1 CACNB4 YES1 PRX SLIT1 PRKACA PRKACB PRKACG ROCK1 PRKCQ | 7.91e-05 | 575 | 158 | 18 | M29853 |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 1.10e-04 | 9 | 158 | 3 | M27877 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 1.27e-04 | 44 | 158 | 5 | M9011 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.36e-04 | 24 | 158 | 4 | M47520 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 1.56e-04 | 10 | 158 | 3 | M47648 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.87e-04 | 26 | 158 | 4 | M47553 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 1.92e-04 | 75 | 158 | 6 | M27032 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.18e-04 | 27 | 158 | 4 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.18e-04 | 27 | 158 | 4 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 2.52e-04 | 28 | 158 | 4 | M47647 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 2.82e-04 | 12 | 158 | 3 | M27950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 2.90e-04 | 29 | 158 | 4 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.90e-04 | 29 | 158 | 4 | M47515 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.10e-04 | 115 | 158 | 7 | M9387 | |
| Pathway | WP_DOPAMINE_METABOLISM | 3.64e-04 | 13 | 158 | 3 | M39622 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.78e-04 | 31 | 158 | 4 | M47507 | |
| Pathway | PID_TXA2PATHWAY | 4.00e-04 | 56 | 158 | 5 | M99 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 4.28e-04 | 32 | 158 | 4 | M27455 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 4.28e-04 | 32 | 158 | 4 | M47506 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 4.58e-04 | 88 | 158 | 6 | M16004 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 5.17e-04 | 90 | 158 | 6 | M6467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 5.69e-04 | 15 | 158 | 3 | M47794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 5.69e-04 | 15 | 158 | 3 | M47504 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 TRPM7 PSMC5 CLCN4 SLC24A4 TRPV2 CREB3L3 VCP CAMK2B RAB11FIP2 ESYT3 ABCB9 SLCO1A2 ASPH PRKACA PRKACB PRKACG MTTP CYB5R4 | 5.85e-04 | 736 | 158 | 19 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 TRPM7 PSMC5 CLCN4 SLC24A4 TRPV2 VCP CAMK2B RAB11FIP2 SLCO1B7 ESYT3 ABCB9 SLCO1A2 ASPH PRKACA PRKACB MTTP CYB5R4 | 6.24e-04 | 681 | 158 | 18 | MM14985 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 6.49e-04 | 130 | 158 | 7 | M27454 | |
| Pathway | PID_GMCSF_PATHWAY | 6.77e-04 | 36 | 158 | 4 | M22 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 6.95e-04 | 16 | 158 | 3 | M923 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 6.95e-04 | 16 | 158 | 3 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 6.95e-04 | 16 | 158 | 3 | M47650 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 8.37e-04 | 17 | 158 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 8.37e-04 | 17 | 158 | 3 | M47544 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 8.86e-04 | 137 | 158 | 7 | M5669 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.90e-04 | 178 | 158 | 8 | M2890 | |
| Pathway | KEGG_MELANOGENESIS | 9.51e-04 | 101 | 158 | 6 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 9.51e-04 | 101 | 158 | 6 | M1979 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.12e-03 | 70 | 158 | 5 | M3115 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.17e-03 | 19 | 158 | 3 | MM1514 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.17e-03 | 19 | 158 | 3 | M3494 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.33e-03 | 43 | 158 | 4 | M933 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.33e-03 | 43 | 158 | 4 | M29837 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.45e-03 | 44 | 158 | 4 | M875 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 1.45e-03 | 44 | 158 | 4 | M42554 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 1.55e-03 | 111 | 158 | 6 | M48065 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.58e-03 | 45 | 158 | 4 | MM14751 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.58e-03 | 21 | 158 | 3 | M27485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 1.58e-03 | 21 | 158 | 3 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 1.58e-03 | 21 | 158 | 3 | M47949 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 7.86e-15 | 14 | 225 | 8 | 19875891 | |
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 7.86e-15 | 14 | 225 | 8 | 15896204 |
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 1.54e-14 | 9 | 225 | 7 | 8662091 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.68e-14 | 15 | 225 | 8 | 20082646 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.68e-14 | 15 | 225 | 8 | 20356536 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.68e-14 | 15 | 225 | 8 | 19926642 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.68e-14 | 15 | 225 | 8 | 20643584 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.68e-14 | 15 | 225 | 8 | 19326408 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 19897003 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 19000141 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 20670355 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 18668235 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 19309280 | |
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 19527230 |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 20652381 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 19279038 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 17868255 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 18643961 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 20331834 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.33e-14 | 16 | 225 | 8 | 20210919 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 19968064 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 20878400 |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 20650299 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 20173784 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 20173792 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 20483367 | |
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 19218127 |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 19450876 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 6.26e-14 | 17 | 225 | 8 | 19761533 | |
| Pubmed | FAT2 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 1.02e-13 | 77 | 225 | 12 | 10835267 | |
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.12e-13 | 18 | 225 | 8 | 19630074 |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.12e-13 | 18 | 225 | 8 | 19046302 |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.12e-13 | 18 | 225 | 8 | 20580654 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.12e-13 | 18 | 225 | 8 | 20519398 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.12e-13 | 18 | 225 | 8 | 19846535 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.12e-13 | 18 | 225 | 8 | 20210918 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | FAT2 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 1.64e-13 | 80 | 225 | 12 | 10716726 |
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.93e-13 | 19 | 225 | 8 | 18571006 |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.93e-13 | 19 | 225 | 8 | 18778326 |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.93e-13 | 19 | 225 | 8 | 20600442 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.93e-13 | 19 | 225 | 8 | 18848853 | |
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 3.19e-13 | 20 | 225 | 8 | 20193031 |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 5.13e-13 | 21 | 225 | 8 | 19861144 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 8.01e-13 | 22 | 225 | 8 | 20492596 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | FAT2 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 1.39e-12 | 72 | 225 | 11 | 10380929 |
| Pubmed | 1.43e-12 | 14 | 225 | 7 | 19489269 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 1.90e-12 | 74 | 225 | 11 | 10817752 |
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 2.66e-12 | 15 | 225 | 7 | 17498266 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 4.70e-12 | 16 | 225 | 7 | 16403292 | |
| Pubmed | 5.67e-12 | 9 | 225 | 6 | 7749980 | ||
| Pubmed | 7.95e-12 | 17 | 225 | 7 | 19032228 | ||
| Pubmed | 7.95e-12 | 17 | 225 | 7 | 19169284 | ||
| Pubmed | GPHN BSN PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA3 PCDHGA12 PAX2 | 9.85e-12 | 44 | 225 | 9 | 19029045 | |
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 1.03e-11 | 29 | 225 | 8 | 20082482 |
| Pubmed | 1.29e-11 | 18 | 225 | 7 | 20200544 | ||
| Pubmed | 1.41e-11 | 10 | 225 | 6 | 12559621 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 2.20e-11 | 68 | 225 | 10 | 11230163 |
| Pubmed | 3.08e-11 | 11 | 225 | 6 | 18830515 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 3.08e-11 | 11 | 225 | 6 | 19664392 | |
| Pubmed | 3.12e-11 | 20 | 225 | 7 | 20426625 | ||
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 4.25e-11 | 34 | 225 | 8 | 22884324 | |
| Pubmed | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 5.48e-11 | 35 | 225 | 8 | 19683555 | |
| Pubmed | 6.13e-11 | 12 | 225 | 6 | 20371502 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 6.13e-11 | 12 | 225 | 6 | 17490516 | |
| Pubmed | 6.13e-11 | 12 | 225 | 6 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 6.13e-11 | 12 | 225 | 6 | 19181658 | |
| Pubmed | 6.13e-11 | 12 | 225 | 6 | 20137308 | ||
| Pubmed | 6.47e-11 | 6 | 225 | 5 | 17882223 | ||
| Pubmed | 1.13e-10 | 13 | 225 | 6 | 19934297 | ||
| Pubmed | 1.13e-10 | 13 | 225 | 6 | 19120281 | ||
| Pubmed | 1.13e-10 | 13 | 225 | 6 | 18687225 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 1.97e-10 | 14 | 225 | 6 | 19421224 | |
| Pubmed | 1.97e-10 | 14 | 225 | 6 | 18945962 | ||
| Pubmed | 3.27e-10 | 15 | 225 | 6 | 19850842 | ||
| Pubmed | 3.27e-10 | 15 | 225 | 6 | 23515096 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 3.27e-10 | 15 | 225 | 6 | 20207982 | |
| Pubmed | 3.27e-10 | 15 | 225 | 6 | 19493232 | ||
| Pubmed | 5.97e-10 | 8 | 225 | 5 | 18681957 | ||
| Pubmed | 1.34e-09 | 9 | 225 | 5 | 18074414 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.71e-09 | 4 | 225 | 4 | 10469592 | |
| Pubmed | 2.66e-09 | 10 | 225 | 5 | 21206914 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 2.29e-08 | 28 | 225 | 6 | 15347688 | |
| Pubmed | 5.88e-08 | 7 | 225 | 4 | 14607943 | ||
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.17e-07 | 8 | 225 | 4 | 17200871 | |
| Pubmed | 1.17e-07 | 8 | 225 | 4 | 15730517 | ||
| Pubmed | Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. | 1.17e-07 | 8 | 225 | 4 | 27365365 | |
| Pubmed | 1.17e-07 | 8 | 225 | 4 | 9430221 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.87e-07 | 94 | 225 | 8 | 21542922 | |
| Pubmed | GPHN PDE1C MARK1 DNAJA2 NCAM1 DHX15 PTK2B SCN2A SVIL SORCS2 BSN CORO7 PRRC2B VCP CPEB2 CACNB4 CAMK2B SYNE1 TUBB FARSB CDC42BPB USP10 USP5 UBE2O PEBP1 CPEB4 PRKACA PCDH1 | 2.06e-07 | 1431 | 225 | 28 | 37142655 | |
| Pubmed | RSF1 NEB FER1L6 CLCN4 CC2D2A PDIA2 DLEC1 BSN SNX9 PRRC2B PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 CAMK2B PCDHGA3 SYNE1 PCDHGA2 PCDHGA1 PRX ABCB9 PCDHGA12 PRKACA PRKACB MTTP POLQ | 2.41e-07 | 1442 | 225 | 28 | 35575683 | |
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 2342480 | ||
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 16698433 | ||
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 30696053 | ||
| Pubmed | Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis. | 2.67e-07 | 3 | 225 | 3 | 22960345 | |
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 19383776 | ||
| Pubmed | CPEB2, a novel putative translational regulator in mouse haploid germ cells. | 2.67e-07 | 3 | 225 | 3 | 12672660 | |
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 12842892 | ||
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 26430804 | ||
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 18292496 | ||
| Pubmed | 8.11e-07 | 12 | 225 | 4 | 14557543 | ||
| Interaction | PCDHGA4 interactions | PCDHGB7 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA12 PCDH1 | 2.11e-09 | 34 | 215 | 8 | int:PCDHGA4 |
| Interaction | PCDHGA12 interactions | 2.52e-06 | 10 | 215 | 4 | int:PCDHGA12 | |
| Interaction | H2BC5 interactions | SPDL1 ATRIP SVIL PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 POLR2A CDC42BPB PCDHGA12 | 2.90e-06 | 331 | 215 | 15 | int:H2BC5 |
| Interaction | ANAPC16 interactions | 5.88e-06 | 65 | 215 | 7 | int:ANAPC16 | |
| Interaction | KIR2DL2 interactions | 8.35e-06 | 13 | 215 | 4 | int:KIR2DL2 | |
| Interaction | KIR2DS5 interactions | 2.07e-05 | 16 | 215 | 4 | int:KIR2DS5 | |
| Interaction | PCDHA9 interactions | 2.10e-05 | 32 | 215 | 5 | int:PCDHA9 | |
| Interaction | PCDHGA9 interactions | 2.45e-05 | 33 | 215 | 5 | int:PCDHGA9 | |
| Interaction | DYNLL2 interactions | GPHN DLG5 HMMR HNF4A NEK1 FBXO42 MTCL1 BSN PRKACA PRKACB PRKACG TP53BP1 | 2.72e-05 | 263 | 215 | 12 | int:DYNLL2 |
| Interaction | KIR2DS3 interactions | 5.34e-05 | 20 | 215 | 4 | int:KIR2DS3 | |
| Interaction | PCDHGA5 interactions | 5.63e-05 | 63 | 215 | 6 | int:PCDHGA5 | |
| Cytoband | 5q31 | P4HA2 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 1.40e-11 | 115 | 225 | 11 | 5q31 |
| Cytoband | 19q13.4 | KIR2DS2 LILRB1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 LILRA1 | 2.12e-10 | 79 | 225 | 9 | 19q13.4 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | SLC23A1 P4HA2 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDH1 | 3.50e-09 | 298 | 225 | 13 | chr5q31 |
| Cytoband | 15q22.3-q23 | 1.43e-04 | 4 | 225 | 2 | 15q22.3-q23 | |
| Cytoband | 18q11.1 | 1.43e-04 | 4 | 225 | 2 | 18q11.1 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 KIR3DS1 KIR3DL3 | 7.18e-13 | 18 | 149 | 8 | 620 |
| GeneFamily | Clustered protocadherins | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 1.10e-10 | 64 | 149 | 10 | 20 |
| GeneFamily | Alpha-1,2-glucosyltransferases | 6.75e-05 | 2 | 149 | 2 | 448 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | KIR2DS2 NCAM1 HMMR LILRB1 CD101 KIR2DL2 KIR2DL3 KIR2DS5 KIR3DL2 LILRA1 KIR3DL3 IL6ST | 1.05e-04 | 394 | 149 | 12 | 471 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.80e-04 | 161 | 149 | 7 | 593 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.24e-03 | 26 | 149 | 3 | 904 | |
| GeneFamily | Fibronectin type III domain containing | 2.12e-03 | 160 | 149 | 6 | 555 | |
| GeneFamily | Acyl-CoA thioesterases | 2.91e-03 | 10 | 149 | 2 | 41 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | 1.50e-07 | 49 | 216 | 7 | M40909 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | ARHGAP42 GPHN ESRP1 FAT2 SORCS2 NHS MTCL1 CACNB4 SYNE1 COL27A1 IGDCC3 C11orf16 | 9.57e-07 | 244 | 216 | 12 | M40312 |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | ARHGAP42 PSEN2 KIR2DS2 NCAM1 COL24A1 KIR2DL2 KIR2DL3 KIR2DS5 PRKACB KIR3DL3 | 4.29e-06 | 190 | 216 | 10 | M4662 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | PADI4 ABCA1 NCAM1 FOXA3 HNF4A IGSF10 OSBPL1A SORCS2 C11orf54 CAMK2B GRIK1 ACOT1 YES1 ESYT3 DAPP1 PRKACB FKBP7 PRKCQ TP53BP1 | 9.26e-06 | 721 | 216 | 19 | M1999 |
| Coexpression | SHEN_SMARCA2_TARGETS_DN | PADI4 TMPRSS15 ADRA2B SCN2A KIR2DS3 KIR3DL2 LILRA1 CAMK2B HSF2BP TEX15 PRX KIR3DL3 | 1.63e-05 | 322 | 216 | 12 | M1676 |
| Coexpression | HAHTOLA_SEZARY_SYNDROM_DN | 2.71e-05 | 43 | 216 | 5 | M18968 | |
| Coexpression | GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 4.31e-05 | 199 | 216 | 9 | M298 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP | 4.48e-05 | 200 | 216 | 9 | M7195 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 4.48e-05 | 200 | 216 | 9 | M6096 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P3 | 5.96e-05 | 161 | 216 | 8 | M1733 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | GPHN AKR1D1 PTK2B PIK3CG CC2D2A SNX9 CACNB4 RBBP6 ST6GAL1 CR1L TBCCD1 PRKCQ EXOC2 IL6ST | 7.27e-05 | 498 | 216 | 14 | M1741 |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.95e-08 | 147 | 213 | 9 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-07 | 170 | 213 | 9 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-07 | 172 | 213 | 9 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TMPRSS15 GGN CREB3L3 GLTPD2 SLC23A1 MGAM2 NAALADL1 PEBP1 MTTP | 2.69e-07 | 184 | 213 | 9 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | GPHN PTK2B SLC24A4 SCN2A CACNB1 CACNB4 CAMK2B RAB11FIP2 PRKACB | 3.23e-07 | 188 | 213 | 9 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | GPHN PTK2B SLC24A4 SCN2A CACNB1 CACNB4 CAMK2B RAB11FIP2 PRKACB | 4.59e-07 | 196 | 213 | 9 | 67400193ba469cf4d939e94f5ed94995e384bc07 |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-06 | 170 | 213 | 8 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.75e-06 | 171 | 213 | 8 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.68e-06 | 181 | 213 | 8 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-06 | 183 | 213 | 8 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.03e-06 | 184 | 213 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 186 | 213 | 8 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | Monocytes-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.36e-06 | 85 | 213 | 6 | e73603d6f22bb56159aa5d1a2695775f038e61d8 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-06 | 187 | 213 | 8 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 3.55e-06 | 188 | 213 | 8 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 3.69e-06 | 189 | 213 | 8 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 190 | 213 | 8 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | PSB-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.84e-06 | 190 | 213 | 8 | e1b5d76edd4c1b95c0a7b94284a65043ab895e67 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 4.48e-06 | 194 | 213 | 8 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 4.65e-06 | 195 | 213 | 8 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 4.65e-06 | 195 | 213 | 8 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.01e-06 | 197 | 213 | 8 | eecb693367510da20a6b1e9355e68785a1e3b85c | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.01e-06 | 197 | 213 | 8 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-06 | 198 | 213 | 8 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.40e-06 | 199 | 213 | 8 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.40e-06 | 199 | 213 | 8 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.40e-06 | 199 | 213 | 8 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 151 | 213 | 7 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 157 | 213 | 7 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 162 | 213 | 7 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-05 | 163 | 213 | 7 | 299ac2463b7f58eee419d822a2a2d64b973d87e9 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 164 | 213 | 7 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 166 | 213 | 7 | 971ee6602a1e751f453f9d823295e63dadce62bf | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 167 | 213 | 7 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-05 | 168 | 213 | 7 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.74e-05 | 113 | 213 | 6 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 170 | 213 | 7 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-05 | 171 | 213 | 7 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 1.88e-05 | 171 | 213 | 7 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 173 | 213 | 7 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 213 | 7 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | IIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster | 2.26e-05 | 176 | 213 | 7 | bb80a3e595d071f6cc8b042984b8d9490e377eef | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 213 | 7 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | IIH-mDC1|IIH / Condition, Cell_class and T cell subcluster | 2.26e-05 | 176 | 213 | 7 | a75dc132a1061006fd1cb305bd314784fca07ea6 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.34e-05 | 177 | 213 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 179 | 213 | 7 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 180 | 213 | 7 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 182 | 213 | 7 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | (5)_Dendritic_cell-(51)_cDC1|(5)_Dendritic_cell / shred on Cell_type and subtype | 2.81e-05 | 123 | 213 | 6 | d46cfdf8b3e561d8db33903207d5151cdb2a91d4 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.90e-05 | 183 | 213 | 7 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.90e-05 | 183 | 213 | 7 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.90e-05 | 183 | 213 | 7 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 2.90e-05 | 183 | 213 | 7 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.00e-05 | 184 | 213 | 7 | 7d9294e5a55964903feda135e5bea0338824ed83 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.22e-05 | 126 | 213 | 6 | 6311cc64320db7e24a09065ebdf054f5f551b182 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.33e-05 | 187 | 213 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.44e-05 | 188 | 213 | 7 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 188 | 213 | 7 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 188 | 213 | 7 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.44e-05 | 188 | 213 | 7 | d5ce3ffe783c322b4765b790e861727e46bc34b3 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 3.44e-05 | 188 | 213 | 7 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 189 | 213 | 7 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 3.56e-05 | 189 | 213 | 7 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 3.56e-05 | 189 | 213 | 7 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-05 | 189 | 213 | 7 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 3.68e-05 | 190 | 213 | 7 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-05 | 190 | 213 | 7 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.68e-05 | 190 | 213 | 7 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | (1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.68e-05 | 190 | 213 | 7 | 268772d2adff34f7175b8474e95b67fd96dc1234 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.68e-05 | 190 | 213 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 191 | 213 | 7 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 191 | 213 | 7 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 3.81e-05 | 191 | 213 | 7 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 3.81e-05 | 191 | 213 | 7 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.94e-05 | 192 | 213 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-05 | 192 | 213 | 7 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 4.07e-05 | 193 | 213 | 7 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.07e-05 | 193 | 213 | 7 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.20e-05 | 194 | 213 | 7 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 4.34e-05 | 195 | 213 | 7 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-05 | 196 | 213 | 7 | 53d1f9e9f009d1417a19ca6f9a83ecdf7776ef88 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-05 | 196 | 213 | 7 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-05 | 196 | 213 | 7 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-05 | 197 | 213 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.63e-05 | 197 | 213 | 7 | 33f2fe101ae5744eea3915add37e60aa398bb97f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-05 | 197 | 213 | 7 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.63e-05 | 197 | 213 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.63e-05 | 197 | 213 | 7 | 9262785807faeb32417fad7ef202405053e453e2 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.63e-05 | 197 | 213 | 7 | d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.63e-05 | 197 | 213 | 7 | 5e9a3932ae5147a3d73dc70f1545926a692930ed | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-05 | 197 | 213 | 7 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.63e-05 | 197 | 213 | 7 | 8a126cfe1529f3d75a806aa492743314a8a43ef9 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.78e-05 | 198 | 213 | 7 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-05 | 198 | 213 | 7 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.78e-05 | 198 | 213 | 7 | e8002972410e4803d85263ba2642e6855cef83e9 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.78e-05 | 198 | 213 | 7 | 2bba5a2f584b00d35d008d9c2d8fb3e712fc3a73 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.78e-05 | 198 | 213 | 7 | 436f3a9ef31b0991765bb97c21960f20fa71d578 | |
| Drug | pristane | PADI4 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 PRKACA PRKACB PRKACG KIR3DL3 IL6ST | 2.23e-07 | 152 | 215 | 11 | CID000015979 |
| Drug | D-Au | LILRB1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 KIR3DL2 VGLL1 KIR3DL3 | 6.68e-07 | 77 | 215 | 8 | CID000277822 |
| Drug | 1c88 | PADI4 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5 YES1 FARS2 SLCO1A2 KIR3DL3 | 3.20e-06 | 126 | 215 | 9 | CID000444766 |
| Drug | NPC 15437 | 4.52e-06 | 46 | 215 | 6 | CID000004548 | |
| Drug | 8-N3cAMP | 7.19e-06 | 14 | 215 | 4 | CID006426627 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | PDE1C PHKG2 PIK3CG CACNB1 CACNB4 NPR2 CAMK2B GRIK1 ACTRT2 PRKACA PRKACB PRKACG ROCK1 | 8.00e-06 | 308 | 215 | 13 | CID000001915 |
| Drug | 5-bromotryptophan | 8.19e-06 | 5 | 215 | 3 | CID000096735 | |
| Drug | Aa1 | 1.37e-05 | 83 | 215 | 7 | CID009549188 | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.90e-05 | 197 | 215 | 10 | 4477_DN | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; PC3; HT_HG-U133A | PADI4 UNC5B ZNF362 ITGB8 CLCN4 CAMSAP1 CACNB1 NPR2 CAMK2B PRKACG | 2.07e-05 | 199 | 215 | 10 | 4568_UP |
| Drug | Tannins | 2.13e-05 | 36 | 215 | 5 | CID000250395 | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | CDC42EP4 IKZF1 SVIL PRRC2B STK25 FOXN2 ST6GAL1 USP5 UBE2O ASPH | 2.16e-05 | 200 | 215 | 10 | 1165_DN |
| Drug | 6-thioguanine; Up 200; 10uM; MCF7; HG-U133A | BICD1 NRSN2 SEMA3B TRPV2 AFF1 CACNB1 ST6GAL1 ABCB9 PAX2 IL6ST | 2.16e-05 | 200 | 215 | 10 | 642_UP |
| Drug | NSC56408 | 2.62e-05 | 62 | 215 | 6 | CID000005604 | |
| Drug | Y base | 2.68e-05 | 19 | 215 | 4 | CID000122034 | |
| Drug | 8-azidoadenosine | 2.68e-05 | 19 | 215 | 4 | CID000160751 | |
| Drug | AMP group | GPHN PDE1C NCAM1 CABYR ADHFE1 ADRA2B AHCY KIR3DL2 FHL5 FARSB FARS2 SLCO1A2 ENTPD3 PRKACA PRKACB PRKACG PRKCQ | 3.88e-05 | 579 | 215 | 17 | CID000000224 |
| Disease | mental development measurement | PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 | 4.62e-12 | 25 | 205 | 8 | EFO_0008230 |
| Disease | childhood trauma measurement, alcohol consumption measurement | PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 | 6.71e-11 | 71 | 205 | 10 | EFO_0007878, EFO_0007979 |
| Disease | Sarcosine measurement | 1.57e-10 | 23 | 205 | 7 | EFO_0021668 | |
| Disease | mean platelet volume | CFAP251 RSF1 IKZF1 SVIL AFF1 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 POLR2A TUBB FRYL CDC42BPB HDAC7 PCDHGA12 CPEB4 | 9.74e-06 | 1020 | 205 | 21 | EFO_0004584 |
| Disease | glucose-dependent insulinotropic peptide measurement | 3.37e-05 | 53 | 205 | 5 | EFO_0008464 | |
| Disease | episodic ataxia (is_implicated_in) | 4.80e-05 | 2 | 205 | 2 | DOID:963 (is_implicated_in) | |
| Disease | inclusion body myopathy with Paget disease of bone and frontotemporal dementia (implicated_via_orthology) | 4.80e-05 | 2 | 205 | 2 | DOID:0050881 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 8.54e-05 | 103 | 205 | 6 | EFO_0008595, EFO_0020944 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.05e-04 | 67 | 205 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 1.43e-04 | 3 | 205 | 2 | OBA_2042107 | |
| Disease | Long Qt Syndrome 2 | 1.43e-04 | 3 | 205 | 2 | C3150943 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.07e-04 | 121 | 205 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | visfatin measurement | 2.09e-04 | 17 | 205 | 3 | EFO_0801230 | |
| Disease | severe acute respiratory syndrome, COVID-19 | GAS2 COL24A1 SLC24A4 NUP210 SORCS2 SLC23A1 MTHFD1L ST6GAL1 NUBPL FARS2 INAVA | 3.16e-04 | 447 | 205 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | X-23756 measurement | 4.74e-04 | 5 | 205 | 2 | EFO_0022126 | |
| Disease | IgG disialylation measurement | 4.74e-04 | 5 | 205 | 2 | EFO_0008429 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.26e-04 | 144 | 205 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.52e-04 | 150 | 205 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | serum gamma-glutamyl transferase measurement | DLG5 TRPM7 HNF4A SLC24A4 FBXO42 SVIL AFF1 SNX9 FOXN2 YES1 CDC42BPB SLCO1B7 SLCO1A2 YY1AP1 PAX2 TP53BP1 | 6.95e-04 | 914 | 205 | 16 | EFO_0004532 |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 7.07e-04 | 6 | 205 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.03e-03 | 291 | 205 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.04e-03 | 225 | 205 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.09e-03 | 111 | 205 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | Stevens-Johnson Syndrome | 1.17e-03 | 30 | 205 | 3 | C0038325 | |
| Disease | right ventricular ejection fraction measurement | 1.17e-03 | 30 | 205 | 3 | EFO_0021816 | |
| Disease | free cholesterol measurement | 1.18e-03 | 113 | 205 | 5 | EFO_0008591 | |
| Disease | IgG digalactosylation measurement | 1.31e-03 | 8 | 205 | 2 | EFO_0008424 | |
| Disease | oxalate measurement | 1.41e-03 | 32 | 205 | 3 | EFO_0010517 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 1.41e-03 | 32 | 205 | 3 | EFO_0000341, EFO_0004325 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 1.67e-03 | 9 | 205 | 2 | EFO_0800562 | |
| Disease | IgG bisecting N-acetyl glucosamine measurement | 1.67e-03 | 9 | 205 | 2 | EFO_0008426 | |
| Disease | IgG monogalactosylation measurement | 1.67e-03 | 9 | 205 | 2 | EFO_0008423 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.98e-03 | 127 | 205 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | esterified cholesterol measurement | 2.04e-03 | 128 | 205 | 5 | EFO_0008589 | |
| Disease | BMI-adjusted waist-hip ratio, asthma | 2.08e-03 | 10 | 205 | 2 | EFO_0007788, MONDO_0004979 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.08e-03 | 10 | 205 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.08e-03 | 10 | 205 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | IgG sialylation measurement | 2.08e-03 | 10 | 205 | 2 | EFO_0008428 | |
| Disease | leptin measurement | 2.48e-03 | 81 | 205 | 4 | EFO_0005000 | |
| Disease | Lewy body dementia | 2.51e-03 | 39 | 205 | 3 | EFO_0006792 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.54e-03 | 11 | 205 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | niacinamide measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0010511 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.03e-03 | 12 | 205 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | IgG galactosylation measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0008425 | |
| Disease | lymphocyte count | IKZF1 SUPV3L1 AFF1 DDX60L CORO7 P4HA2 PCDHGB7 PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA1 MED13L NUBPL HDAC7 UBE2O PCDHGA12 | 3.14e-03 | 1464 | 205 | 20 | EFO_0004587 |
| Disease | serum alanine aminotransferase measurement | DLG5 TRPM7 NDST4 HNF4A CDH20 SUPV3L1 NUP210 AHCY CREB3L3 MTARC1 FOXN2 COL27A1 MTTP FKBP7 | 3.17e-03 | 869 | 205 | 14 | EFO_0004735 |
| Disease | triglycerides in large LDL measurement | 3.32e-03 | 43 | 205 | 3 | EFO_0022319 | |
| Disease | sphingomyelin measurement | 3.43e-03 | 278 | 205 | 7 | EFO_0010118 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 3.56e-03 | 13 | 205 | 2 | EFO_0800474 | |
| Disease | thalamus volume change measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0021496 | |
| Disease | diffuse large B-cell lymphoma | 4.14e-03 | 14 | 205 | 2 | EFO_0000403 | |
| Disease | inflammatory bowel disease | 4.36e-03 | 449 | 205 | 9 | EFO_0003767 | |
| Disease | phosphoglycerides measurement | 4.54e-03 | 48 | 205 | 3 | EFO_0022291 | |
| Disease | mean corpuscular hemoglobin concentration | IKZF1 NEB FOXA3 NEO1 CC2D2A PDIA2 AFF1 MED17 SLC23A1 PCDHGA5 POLR2A HSF2BP LBR HDAC7 CPEB4 EXOC2 | 4.66e-03 | 1105 | 205 | 16 | EFO_0004528 |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 4.73e-03 | 295 | 205 | 7 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | upper face morphology measurement | 4.74e-03 | 97 | 205 | 4 | EFO_0010949 | |
| Disease | forehead morphology measurement | 4.75e-03 | 15 | 205 | 2 | EFO_0007844 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 4.75e-03 | 15 | 205 | 2 | EFO_0008208 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 4.75e-03 | 15 | 205 | 2 | EFO_0801746 | |
| Disease | cortical thickness | MON2 NCAM1 NEO1 CDH20 FBXO42 AFF1 DLEC1 MTCL1 CPVL P4HA2 NPR2 ACTRT2 SLCO1A2 CPEB4 EXOC2 PTPN20 | 4.99e-03 | 1113 | 205 | 16 | EFO_0004840 |
| Disease | triglyceride measurement, alcohol drinking | 5.09e-03 | 99 | 205 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 5.09e-03 | 99 | 205 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | fourth ventricle volume measurement | 5.41e-03 | 16 | 205 | 2 | EFO_0010303 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 5.47e-03 | 101 | 205 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | FEV/FEC ratio | ARHGAP42 PDE1C NCAM1 NEB ITGB8 DHX15 CLCN4 SVIL DLEC1 MTCL1 CPVL PCDHGA5 PCDHGA1 CPEB4 MRPS6 PAX2 EXOC2 | 5.56e-03 | 1228 | 205 | 17 | EFO_0004713 |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 5.59e-03 | 162 | 205 | 5 | EFO_0004612, EFO_0007878 | |
| Disease | total phospholipids in lipoprotein particles measurement | 6.00e-03 | 53 | 205 | 3 | EFO_0022315 | |
| Disease | triglycerides in HDL measurement | 6.00e-03 | 53 | 205 | 3 | EFO_0022317 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 6.06e-03 | 104 | 205 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | respiratory symptom change measurement, response to placebo | 6.10e-03 | 17 | 205 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | caudal anterior cingulate cortex volume measurement | 6.10e-03 | 17 | 205 | 2 | EFO_0010289 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 6.26e-03 | 105 | 205 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 6.26e-03 | 105 | 205 | 4 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | handedness | 6.48e-03 | 106 | 205 | 4 | EFO_0009902 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 6.50e-03 | 168 | 205 | 5 | EFO_0004329, EFO_0004612 | |
| Disease | factor VII measurement | 6.65e-03 | 55 | 205 | 3 | EFO_0004619 | |
| Disease | Diffuse Large B-Cell Lymphoma | 6.65e-03 | 55 | 205 | 3 | C0079744 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.68e-03 | 239 | 205 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | sphingosine 1-phosphate measurement | 6.83e-03 | 18 | 205 | 2 | EFO_0800185 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 6.83e-03 | 18 | 205 | 2 | HP_0002373 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLLYGPPGTGKTLLA | 186 | P62195 | |
| VGGTLRYKGETLPPV | 261 | Q86TX2 | |
| VELAPGSLPQRVKYG | 91 | Q68DN1 | |
| ERELGSPYTGPEALK | 586 | A0FGR9 | |
| GTPGYLTSPELHKEL | 1386 | Q9HCE0 | |
| PLLGAGIYTSNKDPI | 546 | P55198 | |
| ILPGYSIAAKITGPT | 11 | Q6UXZ3 | |
| GPLVKLNGDYRTPTL | 291 | Q96G01 | |
| PIILVGPSLKGYEVT | 231 | Q02641 | |
| EGITLPTQLPLTKYE | 226 | Q68CJ9 | |
| EYKLPDGNIISLGDP | 241 | Q8TDY3 | |
| NSIPIIGLGTYSEPK | 16 | P51857 | |
| PGVDPELYELTTSKL | 846 | Q6ULP2 | |
| PVTLELGGKSPCYVD | 206 | P30838 | |
| VKYGPDPVEIKLESG | 156 | Q6UY09 | |
| VGTPIGSPYRDKITI | 781 | P39086 | |
| PPTSGTAYILGKDIR | 951 | O95477 | |
| LIKGDPAASLPIISY | 31 | Q9C0F1 | |
| YLLSHPEVKGPGVGL | 276 | P49753 | |
| AVISLPPLIYKGDQG | 141 | P18089 | |
| PRLVVPYGLKTLLEG | 6 | O75952 | |
| PGLYLVSVGVVKPAI | 66 | Q5I7T1 | |
| SGPFYLEGLDLSPKE | 721 | P20594 | |
| PYACGSGIPEIKTIL | 176 | P51793 | |
| ESIPYLKEGIESGDP | 506 | Q12797 | |
| DVGRYLETKPADLGP | 146 | Q96G46 | |
| ELSEPLKPGSSYELQ | 191 | Q6Q4G3 | |
| LGPEVGDIKIIPLYS | 376 | O43143 | |
| LKSLGTGAPVIESPY | 101 | P33240 | |
| DGKYVLVAGITPTPL | 411 | Q6UB35 | |
| PDTEEIYKLTGTGPK | 1531 | Q5T5Y3 | |
| PVVLVGPSLKGYEVT | 221 | O00305 | |
| RKTLLGPAYGSPIEQ | 831 | Q8TBY9 | |
| LPPGLKYGIVLDAGS | 51 | O75355 | |
| PITGGKEGILFVTYP | 351 | Q6NXG1 | |
| GSYDDPSVPLLGQVK | 281 | Q8NFF2 | |
| SDLLGKPLGPRTLYV | 191 | Q8IY67 | |
| ELAPRSAEPGYLVTK | 576 | Q9Y5G6 | |
| ELAPRSAEPGYLVTK | 576 | Q9Y5H1 | |
| DPLDIVITGLYEKPS | 116 | P43631 | |
| KSLYGDVDSPLPTGE | 541 | Q9Y4B5 | |
| ELAPRSAEPGYLVTK | 576 | Q9Y5G8 | |
| ELAPRSAEPGYLVTK | 576 | O60330 | |
| PSLLGGTISAYKIVP | 46 | Q9NQX3 | |
| LFYLLPIGKVVEGTP | 271 | Q14739 | |
| DPLDIVITGLYEKPS | 211 | P43630 | |
| PDGGKYPELVLQKTL | 186 | Q9Y5F8 | |
| ISGVYKLPPDDFLGS | 141 | O43827 | |
| TPPVKALLYLTGVEI | 101 | Q9UM07 | |
| ASLSYRVLDGPEKVP | 1316 | Q8TEM1 | |
| TLYSDTIPEDVLPGK | 3026 | Q14517 | |
| STPSAPEGYDLKIGL | 466 | Q6P3S6 | |
| EYIVTQGPLPGTKDD | 1771 | P23467 | |
| ELAPRSAEPGYLVTK | 576 | Q9Y5G7 | |
| DPLDIVITGLYEKPS | 116 | P43627 | |
| GTPEYLAPEIILSKG | 201 | P17612 | |
| GTPDYIAPEILLGQK | 541 | Q04759 | |
| TGGLSKLGLELYPAP | 401 | Q5VTA0 | |
| GSGAYKEPAILVGPE | 231 | Q8IVU1 | |
| PIPTLLVGYDKDFLT | 1381 | Q71F56 | |
| ENPGTIKVGDPVYLL | 321 | Q5VT66 | |
| ASLKPEGDVGLSPYL | 91 | A6NH11 | |
| ISPEGEKYKPLITGE | 836 | Q96PY6 | |
| PGLLITPVLYEGVDE | 711 | Q2M2H8 | |
| DPLDIVITGLYEKPS | 116 | P43628 | |
| LLLAVYTGPGPVKDV | 591 | P98073 | |
| VEARKYGLALDPIPG | 1691 | Q9UPA5 | |
| TDIIEKYGFPPDLTL | 991 | Q5H9U9 | |
| PSYDPDTGLVLLTGK | 736 | P57737 | |
| KGDSGQPLFLTPYIE | 36 | Q9H3G5 | |
| SGSEPYKLLPGAVAT | 441 | P41235 | |
| LKADPIVGSLEPGIY | 766 | Q96KP1 | |
| KALPFSIDPYLGIIS | 501 | Q9NYQ8 | |
| LPGTKLYGPEGLELV | 236 | Q02556 | |
| IPSLLKYAEAGEGPI | 486 | P55157 | |
| ELAPRSAEPGYLVTK | 576 | Q9Y5G4 | |
| PEYNLTITATDGGKP | 416 | Q9Y5G2 | |
| YDLTIKVQDGGSPPR | 246 | Q08174 | |
| LVYSLEPEPAAKGLF | 541 | Q08174 | |
| VGLSYPPAVIEALKD | 151 | Q14123 | |
| GKLYTLVLTDPDAPS | 61 | P30086 | |
| LVVPSDIPKTYGGDT | 2256 | O94915 | |
| DPLDIVVVGLYGKPS | 211 | Q8N743 | |
| KGPDGLVPGDLILEY | 1536 | Q8TDM6 | |
| DLLAVGAPSGYSPKE | 106 | P12525 | |
| DPLDIVITGLYEKPS | 116 | Q14952 | |
| EVGLDGTETYLPPLS | 21 | Q9NVC6 | |
| LETTKKYAPVDGGPV | 341 | Q13087 | |
| GAISYAEVLKQGPLP | 281 | Q86UU5 | |
| GLPGTLYPVIKEETN | 231 | Q13422 | |
| GEKLGRYSSSEPPIV | 1216 | Q7Z3U7 | |
| LFLYDLPEGKSTQPG | 1126 | Q9Y5S2 | |
| DIPPLTDNGKGKYTL | 116 | Q9H3R1 | |
| TTGYAVPPKLEGIGE | 81 | Q9GZP1 | |
| LSDKLIPLFYGVVTP | 276 | Q9NQN1 | |
| TGKPFNPLLGETYEL | 621 | Q9BXW6 | |
| ELCGTPGYLAPEILK | 186 | P15735 | |
| YSLPALTPGLDEVKS | 291 | Q02962 | |
| EKGYQVPVLGTPSLL | 461 | Q7Z6E9 | |
| DPLDIVITGLYEKPS | 116 | Q14953 | |
| DPGTISRGELPGTKY | 146 | O15460 | |
| DILPYDSTRVPLGKS | 191 | Q4JDL3 | |
| PSGLAVYPAVLQDGK | 21 | Q8IZE3 | |
| AEPVAVKSFLPYLLG | 301 | Q8IZE3 | |
| ELAPRSAEPGYLVTK | 576 | Q9Y5H0 | |
| PGAYDVKTLEVLKGP | 21 | O75330 | |
| YKDLLPLLPGTIAGE | 351 | P26012 | |
| ELLYPSPKAGKEVSG | 646 | B2RXH4 | |
| DTKLYDILGVPPGAS | 6 | O60884 | |
| IYPETLKLEGKGPEL | 156 | P87889 | |
| IYPETLKLEGKGPEL | 156 | P62683 | |
| IYPETLKLEGKGPEL | 156 | P63145 | |
| IYPETLKLEGKGPEL | 156 | Q9HDB9 | |
| IYPETLKLEGKGPEL | 156 | Q7LDI9 | |
| IYPETLKLEGKGPEL | 156 | P63130 | |
| IYPETLKLEGKGPEL | 156 | P62685 | |
| IYPETLKLEGKGPEL | 156 | P63126 | |
| IYPETLKLEGKGPEL | 156 | P62684 | |
| KEGYAEGKIPPDATL | 121 | Q9Y680 | |
| PIGTKPLISKESGNY | 136 | Q5TD97 | |
| LEIGQKPVILTYAPG | 2426 | Q6WRI0 | |
| LSKDFILVPGPLYTE | 201 | Q93033 | |
| ADGPGSPESIKAYLK | 501 | P40189 | |
| GTPEYLAPEIILSKG | 201 | P22694 | |
| GTPEYLAPEIILSKG | 201 | P22612 | |
| GTFKIDIPPVLLGYS | 1201 | Q9P2K1 | |
| GIDTDPELKYPKGAG | 471 | Q7Z5Q1 | |
| DLPETVPYLKIFTVG | 151 | O75319 | |
| IDTDPELKYPKGAGR | 581 | Q8NE35 | |
| KLAELYGASEGPAPL | 786 | Q9HBT6 | |
| LGDPSYVQVAPETKG | 1481 | Q5JV73 | |
| TPIFGGRPLDILTYK | 461 | O75417 | |
| HTGTPLGDIPYGKEV | 486 | Q2VPA4 | |
| DLVPTAPSLGTKEGY | 156 | Q9UN19 | |
| DLTDLPVVPKATYGL | 186 | Q9H3Q1 | |
| PPLTDIGVLYEGKER | 96 | Q5VZ89 | |
| LPPASSGKQYRLEVG | 1841 | Q8IZC6 | |
| LPTIKDGSEAYRPGT | 566 | Q9P0L2 | |
| SEGLPIVSPLYDIEG | 76 | P32314 | |
| GIDTDPELKYPKGAG | 611 | Q17RY0 | |
| LPEEGSPGAVYLLSK | 276 | Q5BKX5 | |
| ESGYKPLVGREDSKP | 266 | Q8WXE1 | |
| GIPYRTLEPLETEGA | 111 | Q8WUI4 | |
| LTPEKEVGYLEFTGP | 841 | Q14289 | |
| IYISGEKSQPDPGEL | 596 | Q9Y238 | |
| KVGSPLDYSLVDLPS | 1356 | Q96T23 | |
| PEGGLVPKSLYRTAE | 496 | Q92503 | |
| TKYPQLLPGIRGISE | 141 | P23526 | |
| ELTGTLPAEYPLKPG | 146 | Q3KP66 | |
| IGLLDVDVYGPSVPK | 101 | Q8TB37 | |
| ELAPLSAEPGYLVTK | 576 | Q9Y5H4 | |
| LDYVSAPIGKGKPVS | 161 | Q8IWW8 | |
| GPPLAGLLVDQSKIY | 436 | O15403 | |
| AARYGVEPPGLIKLE | 156 | O43903 | |
| PEYLGATVAAPVVKL | 911 | Q2WGJ9 | |
| GLKYISESPGFIPLL | 246 | O75031 | |
| GTPGYLSPEVLRKEA | 176 | Q13554 | |
| YKTKPGVPEGNLTLS | 1141 | O75445 | |
| VSPRKPNGIILGYDL | 3131 | O75445 | |
| LVPTDYVEILPSDGK | 51 | Q9Y5X1 | |
| ITLTLDPLKPFGGYS | 116 | Q9NWD8 | |
| EGIVPVPLAEKLYST | 106 | P82932 | |
| LELPSSKTEGPYGEI | 571 | O95425 | |
| RLLSGVPLYKGDVPT | 6331 | Q8NF91 | |
| SDPLELVVTGAYIKP | 111 | O75019 | |
| SDPLELVVTGAYIKP | 111 | Q8NHL6 | |
| DGKIIQYGPGPDETL | 1286 | Q6T4R5 | |
| SPYLRTVGEKLLPGI | 231 | O60502 | |
| LFLGPYKGRSTELIP | 291 | O60502 | |
| PIDLVKKEPYGLSGL | 716 | A6NI28 | |
| PYFTGLELPGELKLD | 281 | P55318 | |
| SKPSPIYGGLVLIVS | 21 | P03923 | |
| DPLDIVVTGLYEKPS | 211 | Q14943 | |
| GTPEYLAPEVIQSKG | 206 | O43930 | |
| GGPPKYSDEVELKVL | 226 | Q92859 | |
| VVKPGLPTLADLYVL | 1006 | Q96PQ0 | |
| SALGGEVYRLPPQKE | 471 | Q96EA4 | |
| GPTTPYGKTLIKVAE | 106 | Q9NR46 | |
| EGYLPKESIRTKAGP | 166 | P15907 | |
| YSVSGDEKKGPLIAP | 11 | P48029 | |
| GETPILPLGISYIED | 171 | P46721 | |
| IGETPIVPLGISYID | 136 | G3V0H7 | |
| ESAVIYGSLPPGTKL | 391 | Q8IYB8 | |
| LIKIYPTGLFTPELD | 351 | Q7L1T6 | |
| APDEYLVSPITGEKI | 406 | Q15459 | |
| LLKPGPLEETYIATI | 106 | O00506 | |
| LLDVPPGEDKGGYVI | 521 | Q9NSD9 | |
| IYPETLKLEGKGPEL | 156 | P63128 | |
| YPLEGGRVLLDGKPI | 556 | Q9NP78 | |
| EPGLLPYGSRDQTSK | 626 | P51825 | |
| PGLYLVSIGVIKPAI | 66 | Q5BKT4 | |
| SPSVGYSLRPGDKVL | 146 | Q9NQ32 | |
| KTRIAEVGGVPYLLP | 56 | Q9H0W9 | |
| QPLSGLVDDYGILPK | 51 | C9JXX5 | |
| PKGEKGYPGEDSTVL | 1186 | Q17RW2 | |
| EPEATGGVPILKYKA | 531 | P13591 | |
| PRSILPKEYGGTAGE | 266 | Q9BTX7 | |
| PYDPGLKAGALAIEK | 786 | P48736 | |
| GLAIKPGTSVEYLAP | 116 | Q2QD12 | |
| LTLTDVLPTDPKAYG | 271 | Q9UHI7 | |
| ILLYGPPGTGKTLIA | 241 | P55072 | |
| LDPGRIEDGKGKSPY | 156 | Q13214 | |
| PAIKDGIAQLTYAGP | 276 | Q8WZ04 | |
| ALRPGTVSGYEIKGP | 106 | Q9BXM0 | |
| IKYPETTEGGRPKLG | 41 | P24928 | |
| LEAGKSLPFIYGDIP | 56 | Q99250 | |
| GGKYVPRAILVDLEP | 56 | P07437 | |
| SALIKGPTRTPYEDG | 986 | Q9C0C9 | |
| GVPEDLAGLPEYLSK | 86 | Q9Y5S1 | |
| KEKGVLDLSYGPGPS | 186 | Q5JSZ5 | |
| RPPGLEEELTLKYGA | 71 | P49810 | |
| VIGLPYIKPGLSLSV | 211 | Q8N816 | |
| EPGEGPVLLIALYKA | 56 | P0DPF4 | |
| FELPGLLIQGSPEKY | 66 | Q7L804 | |
| GLGPYEAVTPLTKAA | 1601 | Q12888 | |
| ERTLGGYLVEEPKPL | 731 | Q8IZJ1 | |
| GTPEYLAPEVIQSKG | 206 | P51817 | |
| GTPDYISPEVLKSQG | 236 | Q13464 | |
| GSETRYPLLLPKGVV | 421 | Q9H869 | |
| PLPGVTYSGTDRKLA | 491 | A7E2V4 | |
| PYPILASGETAKEGK | 211 | Q5T0B9 | |
| YPVDLEISKELLSPG | 706 | Q14694 | |
| TPDLEVGKKLPFIYG | 41 | Q01118 | |
| EIPGGLPSVYQKALG | 481 | Q9NVR7 | |
| VGEERKGPLPKSYAI | 1021 | Q9BXT5 | |
| GLAIKPGTSVEYLAP | 116 | Q96AT9 | |
| PKGIPKNVTELYLDG | 756 | O75093 | |
| APGSVVELLGKSYPQ | 46 | O95363 | |
| LPNETLSELETPGKY | 226 | Q99990 | |
| LPYLGDTDPLKAAGL | 96 | O95416 | |
| LPPGYKITLIDIGLV | 501 | Q96QT4 | |
| GYPLAVKLGTITPDG | 241 | P45974 | |
| LQTELVTKGRVPYPG | 461 | P07947 | |
| KEIRSPGPGDLSIYD | 471 | Q9UQQ1 | |
| LYKENLGKGIPTPIT | 6246 | P20929 |